constant diarrhea glp 1 GLP-1 and health: Beyond weight loss in the Ozempic era Q&A: Liraglutide outperforms colesevelam in

meta-analysis: OR = 0.90, 95% CI [0.741.09]), and autism (FinnGen: OR = 0.42, 95% CI [0.320.54]

August 8 Product: Citius Pharmaceuticals Lymphir Indication : T cell lymphoma Citius scored approval Thursday for Lymphirthe only treatment for cutaneous T cell lymphoma that targets the IL-2 receptor located on malignant T cells and Tregs

This weight loss injection is a dual incretin agonist that simultaneously targets GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors

Ozempic is the brand name prescribed for diabetes and Wegovy is the brand name for weight loss

Patients concerned about alcohol consumption should be referred to appropriate addiction services